These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 25467757)

  • 21. The Hippo Signaling Transducer TAZ Regulates Mammary Gland Morphogenesis and Carcinogen-induced Mammary Tumorigenesis.
    Denson KE; Mussell AL; Shen H; Truskinovsky A; Yang N; Parashurama N; Chen Y; Frangou C; Yang F; Zhang J
    Sci Rep; 2018 Apr; 8(1):6449. PubMed ID: 29691438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In Vitro Validation of the Hippo Pathway as a Pharmacological Target for Canine Mammary Gland Tumors.
    Guillemette S; Rico C; Godin P; Boerboom D; Paquet M
    J Mammary Gland Biol Neoplasia; 2017 Sep; 22(3):203-214. PubMed ID: 28822004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A kinome-wide screen using a NanoLuc LATS luminescent biosensor identifies ALK as a novel regulator of the Hippo pathway in tumorigenesis and immune evasion.
    Nouri K; Azad T; Lightbody E; Khanal P; Nicol CJ; Yang X
    FASEB J; 2019 Nov; 33(11):12487-12499. PubMed ID: 31431076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Down-regulated long non-coding RNA RNAZFHX4-AS1 suppresses invasion and migration of breast cancer cells via FAT4-dependent Hippo signaling pathway.
    Li SY; Wang H; Mai HF; Li GF; Chen SJ; Li GS; Liang BC
    Cancer Gene Ther; 2019 Nov; 26(11-12):374-387. PubMed ID: 30546116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of the Hippo signalling effectors YAP and TAZ in canine mammary gland hyperplasia and malignant transformation of mammary tumours.
    Rico C; Boerboom D; Paquet M
    Vet Comp Oncol; 2018 Dec; 16(4):630-635. PubMed ID: 30117264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mammary Development and Breast Cancer: a Notch Perspective.
    Chen W; Wei W; Yu L; Ye Z; Huang F; Zhang L; Hu S; Cai C
    J Mammary Gland Biol Neoplasia; 2021 Sep; 26(3):309-320. PubMed ID: 34374886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CRABP2 regulates invasion and metastasis of breast cancer through hippo pathway dependent on ER status.
    Feng X; Zhang M; Wang B; Zhou C; Mu Y; Li J; Liu X; Wang Y; Song Z; Liu P
    J Exp Clin Cancer Res; 2019 Aug; 38(1):361. PubMed ID: 31419991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Hippo-YAP pathway: new connections between regulation of organ size and cancer.
    Zhao B; Lei QY; Guan KL
    Curr Opin Cell Biol; 2008 Dec; 20(6):638-46. PubMed ID: 18955139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hippo signaling in stress response and homeostasis maintenance.
    Mao B; Gao Y; Bai Y; Yuan Z
    Acta Biochim Biophys Sin (Shanghai); 2015 Jan; 47(1):2-9. PubMed ID: 25476206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphodiesterase 5/protein kinase G signal governs stemness of prostate cancer stem cells through Hippo pathway.
    Liu N; Mei L; Fan X; Tang C; Ji X; Hu X; Shi W; Qian Y; Hussain M; Wu J; Wang C; Lin S; Wu X
    Cancer Lett; 2016 Aug; 378(1):38-50. PubMed ID: 27179930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging role of Hippo signalling pathway in bladder cancer.
    Xia J; Zeng M; Zhu H; Chen X; Weng Z; Li S
    J Cell Mol Med; 2018 Jan; 22(1):4-15. PubMed ID: 28782275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stem cells in normal mammary gland and breast cancer.
    Luo J; Yin X; Ma T; Lu J
    Am J Med Sci; 2010 Apr; 339(4):366-70. PubMed ID: 20224316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. STARD13-correlated ceRNA network-directed inhibition on YAP/TAZ activity suppresses stemness of breast cancer via co-regulating Hippo and Rho-GTPase/F-actin signaling.
    Zheng L; Xiang C; Li X; Guo Q; Gao L; Ni H; Xia Y; Xi T
    J Hematol Oncol; 2018 May; 11(1):72. PubMed ID: 29848346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The roles of the Hippo pathway in cancer metastasis.
    Janse van Rensburg HJ; Yang X
    Cell Signal; 2016 Nov; 28(11):1761-72. PubMed ID: 27519476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hippo pathway - brief overview of its relevance in cancer.
    Zygulska AL; Krzemieniecki K; Pierzchalski P
    J Physiol Pharmacol; 2017 Jun; 68(3):311-335. PubMed ID: 28820389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Hippo pathway in intestinal regeneration and disease.
    Hong AW; Meng Z; Guan KL
    Nat Rev Gastroenterol Hepatol; 2016 Jun; 13(6):324-37. PubMed ID: 27147489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vestigial-like family member 3 (VGLL3), a cofactor for TEAD transcription factors, promotes cancer cell proliferation by activating the Hippo pathway.
    Hori N; Okada K; Takakura Y; Takano H; Yamaguchi N; Yamaguchi N
    J Biol Chem; 2020 Jun; 295(26):8798-8807. PubMed ID: 32385107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hedgehog signaling in mammary gland development and breast cancer.
    Hatsell S; Frost AR
    J Mammary Gland Biol Neoplasia; 2007 Sep; 12(2-3):163-73. PubMed ID: 17623270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MARK4 inhibits Hippo signaling to promote proliferation and migration of breast cancer cells.
    Heidary Arash E; Shiban A; Song S; Attisano L
    EMBO Rep; 2017 Mar; 18(3):420-436. PubMed ID: 28183853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Scutellarin Inhibits Proliferation, Invasion, and Tumorigenicity in Human Breast Cancer Cells by Regulating HIPPO-YAP Signaling Pathway.
    Hou L; Chen L; Fang L
    Med Sci Monit; 2017 Oct; 23():5130-5138. PubMed ID: 29079722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.